ArticleInternational journal of nanomedicine2026

Rituximab-Conjugated DART Nanoformulation for CD20-Targeted Drug Delivery in Non-Hodgkin Lymphoma.

Md Musavvir Mahmud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.